The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination

The varicella-zoster virus (VZV) vaccine strain may reactivate to cause herpes zoster. Limited data suggest that the risk of herpes zoster in vaccinated children could be lower than in children with naturally acquired varicella. We examine incidence trends, risk and epidemiologic and clinical featur...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The Pediatric infectious disease journal Ročník 28; číslo 11; s. 954
Hlavní autoři: Civen, Rachel, Chaves, Sandra S, Jumaan, Aisha, Wu, Han, Mascola, Laurene, Gargiullo, Paul, Seward, Jane F
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.11.2009
Témata:
Adolescent
California - epidemiology
Chickenpox Vaccine - administration & dosage
Chickenpox Vaccine - immunology
Child
Child, Preschool
Female
Herpes Zoster - epidemiology
Herpes Zoster - pathology
Herpes Zoster - prevention & control
Herpesvirus 3, Human - immunology
Humans
Incidence
Infant
Interviews as Topic
Male
Risk Factors
Young Adult
California
ISSN:1532-0987, 1532-0987
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The varicella-zoster virus (VZV) vaccine strain may reactivate to cause herpes zoster. Limited data suggest that the risk of herpes zoster in vaccinated children could be lower than in children with naturally acquired varicella. We examine incidence trends, risk and epidemiologic and clinical features of herpes zoster disease among children and adolescents by vaccination status. Population-based active surveillance was conducted among <20 years old residents in Antelope Valley, California, from 2000 through 2006. Structured telephone interviews collected demographic, varicella vaccination and disease histories, and clinical information. From 2000 to 2006, the incidence of herpes zoster among children<10 years of age declined by 55%, from 42 cases reported in 2000 (74.8/100,000 persons; 95% confidence interval [95% CI]: 55.3-101.2) to 18 reported in 2006 (33.3/100,000; 95% CI: 20.9-52.8; P<0.001). During the same period, the incidence of herpes zoster among 10- to 19-year-olds increased by 63%, from 35 cases reported in 2000 (59.5/100,000 persons; 95% CI: 42.7-82.9) to 64 reported in 2006 (96.7/100,000; 95% CI: 75.7-123.6; P<0.02). Among children aged<10 years, those with a history of varicella vaccination had a 4 to 12 times lower risk for developing herpes zoster compared with children with history of varicella disease. Varicella vaccine substantially decreases the risk of herpes zoster among vaccinated children and its widespread use will likely reduce overall herpes zoster burden in the United States. The increase in herpes zoster incidence among 10- to 19-year-olds could not be confidently explained and needs to be confirmed from other data sources.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1532-0987
1532-0987
DOI:10.1097/INF.0b013e3181a90b16